(Q37511726)

20 August 2017

1 reference

title

The socioeconomic burden of SLE. (English)

1 reference

20 August 2017

0 references

Chak Sing Lau

1

1 reference

20 August 2017

Anselm Mak

series ordinal

2

1 reference

20 August 2017

language of work or name

English

0 references

publication date

9 June 2009

1 reference

Nature Reviews Rheumatology

20 August 2017

1 reference

20 August 2017

5

1 reference

20 August 2017

400-404

1 reference

20 August 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2009.106

20 August 2017

0 references

cites work

Epidemiology of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Lupus in the developing world--is it any different?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Mortality and causes of death in systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Neuropsychiatric damage in Southern Chinese patients with systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Prevalence and predictors of fragility fractures in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Ethnic and geographical differences in systemic lupus erythematosus: an overview

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Risk and predictors of work disability in Chinese patients with systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

The systemic lupus erythematosus Tri-nation Study: absence of a link between health resource use and health outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Total costs and predictors of costs in patients with systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

SLE patients with renal damage incur higher health care costs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

The systemic lupus erythematosus Tri-Nation study: cumulative indirect costs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Disease activity, cumulative damage and quality of life in systematic lupus erythematosus: results of a cross-sectional study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Validation of the Chinese SF-36 for quality of life assessment in patients with systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

The systemic lupus erythematosus tri-nation study: longitudinal changes in physical and mental well-being.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

The MOS 36-ltem Short-Form Health Survey (SF-36)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Quality of life in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

A review of health related quality of life in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Impact of disease activity and cumulative damage on the health of lupus patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Quality of life comparison between corticosteroid- and-mycofenolate mofetil and corticosteroid- and-oral cyclophosphamide in the treatment of severe lupus nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.106

How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses?

31 March 2020

1 reference

12 December 2020

Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.

1 reference

12 December 2020

Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus.

1 reference

12 December 2020

A prospective study of factors affecting quality of life in systemic lupus erythematosus.

1 reference

12 December 2020

The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus.

1 reference

12 December 2020

Quality of life in systemic lupus erythematosus: a controlled study.

1 reference

12 December 2020

Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study Group.

1 reference

12 December 2020

An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation Study Group.

1 reference

12 December 2020

Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore.

1 reference

12 December 2020

The relationship between neuropsychiatric, clinical, and laboratory variables and quality of life of Chinese patients with systemic lupus erythematosus.

1 reference

12 December 2020

Decorative cosmetics improve the quality of life in patients with disfiguring skin diseases

1 reference

12 December 2020

High prevalence of unemployment in patients with systemic lupus erythematosus: association with organ damage and health-related quality of life

1 reference

12 December 2020

Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95.

1 reference

12 December 2020

A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2009.106

1 reference

Dimensions Publication ID

20 August 2017

0 references

1 reference